Citigroup »

Mink Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $958 91 10.53

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Mink Therapeutics

Vanguard Group
Vanguard Capital Management
Longbow Finance SA
UBS Group
Geode Capital Management
Renaissance Technologies
Vanguard Fiduciary Trust
BlackRock
Steward Partners Investment Advisory
Tower Research Capital
Annis Gardner Whiting Capital Advisors
Covestor
Advisor Group Holdings
Citigroup
Northwestern Mutual Wealth Management Company

View all funds holding Mink Therapeutics